Abstract-We analyzed the association of 2 biallelic polymorphisms of CYP11B2 (P450c11AS) gene (1 in the Lys 173 Arg of exon 3 and the other in the promoter at position Ϫ344T/C) with hypertension in 73 hypertensive patients and 134 normotensive subjects. The association between low-renin hypertension and angiotensin I-converting enzyme (ACE) gene was also analyzed. An elevated ratio of plasma aldosterone concentration to plasma renin activity was used to identify low-renin hypertension. Genotypes for CYP11B2 and ACE were determined through polymerase chain reactions. The Arg 173 allele frequency did not differ between hypertensive patients considered as 1 group (34%) and normotensive control subjects (37%). However, only 22% of 58 CYP11B2 alleles studied in 29 patients with low-renin hypertension were Arg 173 alleles, whereas the frequency of this allele was 41% in patients with normal-or high-renin hypertension (Pϭ0.033). An analysis of the distribution of Ϫ344C and Arg 173 genotypes indicated that these 2 variants were in complete linkage disequilibrium: Ϫ344C was present in a subset of chromosomes carrying the Arg 173 (PϽ0.001 in low-renin hypertension). Therefore, the frequency of the Ϫ344C allele was low in the patients with low-renin hypertension compared with those with normal-or high-renin hypertension. Deletion (D) allele frequencies of the ACE gene were 31% in the patients with low-renin hypertension, 39% in the patients with normal-or high-renin hypertension, and 29% in normotensive control subjects. We detected an association between the CYP11B2 gene polymorphisms and low-renin hypertension with inappropriate elevation of aldosterone. The decreased frequencies of the Arg 173 and Ϫ344C variants in the CYP11B2 appear to be genetically linked to low-renin hypertension in the Japanese population studied. Key Words: hypertension, essential Ⅲ cytochrome P-450 Ⅲ polymorphism Ⅲ aldosterone Ⅲ renin-angiotensin system E ssential hypertension is thought to be a polygenic disease. Many gene polymorphisms have been proposed as possible markers for hypertension, including insertion/deletion (I/D) polymorphism of the angiotensin I-converting enzyme (ACE) gene, 1 A1161C polymorphism of the angiotensin II type I receptor gene, 2 and M235T angiotensinogen polymorphism. 3,4 The renin-angiotensin-aldosterone system (RAS) is a key mechanism in the regulation of blood pressure. In addition to the vasoactive action, angiotensin II is a potent stimulus of aldosterone synthesis, which results in sodium and water retention.We have reported that 12.4% of 436 Japanese hypertensive patients had low plasma renin activity (PRA) combined with a normal plasma aldosterone concentration (PAC), resulting in an elevated ratio of PAC to PRA (PAC/PRA), 5,6 and we found that so-called pressure natriuresis was incomplete in this subgroup of patients. 6,7 The inappropriate elevation of aldosterone in such hypertensive individuals suggests persistent mineralocorticoid synthesis despite minimal stimulation of RAS. The biosynthesis of aldosteron...